Publication | Open Access
Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials
16
Citations
0
References
2018
Year
Biomarker (Medicine)Novel TherapyInhibitor M3814MedicineBiomarker TargetReceptor Tyrosine KinaseDna-dependent Protein KinaseMolecular DiagnosticsPharmacologyRadiation OncologyClinical ActivityCancer ResearchDrug Discovery
No additional data available for this publication yet. Check back later!